Alpha Tau Medical Ltd. (NASDAQ:DRTS – Get Rating) gapped up before the market opened on Tuesday . The stock had previously closed at $8.63, but opened at $10.21. Alpha Tau Medical shares last traded at $11.03, with a volume of 190 shares traded.
A number of equities research analysts recently commented on the company. Piper Sandler assumed coverage on Alpha Tau Medical in a research report on Friday, April 8th. They set an “overweight” rating and a $19.00 price target on the stock. Cantor Fitzgerald assumed coverage on Alpha Tau Medical in a research report on Thursday, April 14th. They set an “overweight” rating and a $20.00 price target on the stock. Finally, Citigroup assumed coverage on Alpha Tau Medical in a report on Monday, April 4th. They set a “buy” rating and a $21.00 price objective on the stock.
The company’s 50 day simple moving average is $8.38.
A number of hedge funds have recently modified their holdings of DRTS. Clear Street LLC acquired a new stake in Alpha Tau Medical during the first quarter worth approximately $30,000. Ergoteles LLC acquired a new stake in Alpha Tau Medical during the first quarter worth approximately $146,000. Finally, Penserra Capital Management LLC acquired a new stake in Alpha Tau Medical during the first quarter worth approximately $40,000. Hedge funds and other institutional investors own 81.91% of the company’s stock.
About Alpha Tau Medical (NASDAQ:DRTS)
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. Its Alpha-DaRT technology used in clinical trials for skin, oral, pancreatic, and breast cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others.
- Get a free copy of the StockNews.com research report on Alpha Tau Medical (DRTS)
- Is This A Buyable Bottom For Braze, Inc Shares?
- What To Make Of Tesla Right Now
- NortonLifeLock: Developments in Avast Merger and Improved Fundamentals
- Applied Materials Stock a Supply Chain Regain Play
- Plug Your Nose to Buy Plug Power Stock
Receive News & Ratings for Alpha Tau Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alpha Tau Medical and related companies with MarketBeat.com's FREE daily email newsletter.